Cargando…

Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis

We conducted a systematic review and meta-analysis to assess the evidence for the postulation that inappropriate tuberculosis (TB) regimens are a risk for development of multidrug-resistant (MDR)-TB. MEDLINE, EMBASE and other databases were searched for relevant articles in January 2011. Cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Werf, Marieke J., Langendam, Miranda W., Huitric, Emma, Manissero, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2012
Materias:	Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365250/ https://www.ncbi.nlm.nih.gov/pubmed/22005918 http://dx.doi.org/10.1183/09031936.00125711

Ejemplares similares

Knowledge of tuberculosis-treatment prescription of health workers: a systematic review
por: van der Werf, Marieke J., et al.
Publicado: (2012)

Prevalence of inappropriate tuberculosis treatment regimens: a systematic review
por: Langendam, M.W., et al.
Publicado: (2012)

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones
por: Migliori, Giovanni Battista, et al.
Publicado: (2012)

Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review
por: Sandgren, Andreas, et al.
Publicado: (2014)

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union
por: van der Werf, Marieke J., et al.
Publicado: (2017)

Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review
por: Langendam, Miranda W., et al.
Publicado: (2013)

Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015
por: Ködmön, Csaba, et al.
Publicado: (2017)

The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic
por: Reynolds, Daniel, et al.
Publicado: (2022)

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
por: Skripconoka, Vija, et al.
Publicado: (2013)

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
por: He, Guang Xue, et al.
Publicado: (2011)

Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment
por: He, Guang Xue, et al.
Publicado: (2010)

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient
por: Helbling, P., et al.
Publicado: (2018)

Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series
por: Tan, Xing, et al.
Publicado: (2019)

Acute-onset postoperative endophthalmitis caused by multidrug-resistant Klebsiella pneumoniae
por: Sanghi, Shekhar, et al.
Publicado: (2014)

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
por: Harausz, Elizabeth P., et al.
Publicado: (2018)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences
por: de Vries, Gerard, et al.
Publicado: (2017)

Assessing Tuberculosis Case Fatality Ratio: A Meta-Analysis
por: Straetemans, Masja, et al.
Publicado: (2011)

Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis
por: Alene, Kefyalew Addis, et al.
Publicado: (2018)

Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan
por: Chen, Meng-Yu, et al.
Publicado: (2017)

Diagnosis and treatment of multidrug-resistant tuberculosis
por: Jang, Jong Geol, et al.
Publicado: (2020)

The role of telemonitoring in patients on home mechanical ventilation
por: van den Biggelaar, Ries, et al.
Publicado: (2023)

Noninvasive respiratory support after extubation: a systematic review and network meta-analysis
por: Boscolo, Annalisa, et al.
Publicado: (2023)

The Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-Analysis
por: Straetemans, Masja, et al.
Publicado: (2010)

Autologous Free Fascia Lata Can Be Used as Dura Graft in the Salvage Treatment of Recalcitrant Postcraniotomy Intracranial Infection Caused by Multidrug-Resistant Gram-Negative Bacteria
por: Zeng, Tao, et al.
Publicado: (2022)

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)

Pharmacotherapy for multidrug resistant tuberculosis
por: Chhabra, Naveen, et al.
Publicado: (2012)

The Threat of Multidrug-resistant Tuberculosis
por: Paul, Rudrajit
Publicado: (2018)

Fistulized multidrug-resistant tuberculosis
por: El Omri, Naoual, et al.
Publicado: (2017)

Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
por: Johnston, James C., et al.
Publicado: (2009)

Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults
por: Guan, Yanmin, et al.
Publicado: (2020)

Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis
por: Byrne, Anthony L., et al.
Publicado: (2017)

Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
por: Shim, Tae Sun, et al.
Publicado: (2013)

Profile of delamanid for the treatment of multidrug-resistant tuberculosis
por: Szumowski, John D, et al.
Publicado: (2015)

Predictors of Treatment Success for Multidrug Resistant Tuberculosis
por: Park, Sang Won
Publicado: (2016)

Treatment Outcomes Associated with Multidrug-resistant Tuberculosis
por: Gupta, Nitin, et al.
Publicado: (2018)

Nomogram for individualized prediction of incident multidrug-resistant tuberculosis after completing pulmonary tuberculosis treatment
por: Cheng, Qinglin, et al.
Publicado: (2020)

Wealth Inequality and Tuberculosis Elimination in Europe
por: Suk, Jonathan E., et al.
Publicado: (2009)

Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis
por: Liu, Qianqian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kgrgeh44f52p4mv7q2d9ffsjkn